Evan Masingill
GenBioPro, which manufactures only the abortion medications mifepristone and misoprostol, has a 'North Star' that guides its work, Masingill says: reproductive freedom for all people. Masingill says the company's tagline since it was launched in 2012 is 'putting access into practice.' And GenBioPro has committed to that core value. In 2019, the company obtained approval from the U.S. Food and Drug Administration (FDA) to sell the first generic mifepristone tablet in the U.S., which GenBioPro said 'has helped stabilize supply and satisfy the rising demand among patients for medical abortion.' Medication abortion is the most common method of abortion in the U.S. and has become essential for people living in states where abortion is banned or restricted.
GenBioPro is now fighting to protect access to its products. In February, GenBioPro asked a Texas court to include the company as a defendant in a lawsuit filed by state attorneys general from Missouri, Idaho, and Kansas that is seeking to roll back a series of FDA policies implemented during the Biden Administration that have facilitated access to medication abortion. One change the state attorneys general are seeking, for instance, is reinstating the requirement that mifepristone be dispensed in person rather than by mail. In October, GenBioPro urged a federal appeals court to side with it in a lawsuit it filed against West Virginia in 2023 over the state's near-total abortion ban, arguing that the FDA's approval of abortion pills supersedes the state's ban.
Masingill says this work is necessary and that there will always be people in power who try to restrict access to care.
'Does it grind my gears or get me heated?' he says. 'Of course. Is it sad? Yeah. But that doesn't mean we can't do anything.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Becton, Dickinson and Company Submits Application to the FDA for a New, At-Home HPV Test
Becton, Dickinson and Company (NYSE:BDX) is one of the . On July 31, Becton, Dickinson and Company (NYSE:BDX) announced that it submitted an application to the U.S. FDA for a new, at-home HPV test. The new HPV test focuses on patients to self-collect a sample at their home using a swab, the size of a Q-tip, simplifying lab processing. According to BD, this method also reports more high-risk strains of HPV compared to other tests on the market today. A person wearing a state-of-the-art medical device for nerve conduction tests. 'We envision a world where women are empowered with access and a choice for their HPV screening, whether it be in a routine visit at the doctor's office or the comfort and privacy of their own home via a self-collected sample. Cervical cancer and the loss of more than 4,000 women per year to this devastating disease is preventable, and we believe at-home testing is an important leap forward to our goal of eliminating this type of cancer,' said Nikos Pavlidis, president of BD Diagnostic Solutions. BD's new HPV test will include a state-of-the-art self-collection swab technology that also offers convenient mailing from home to the lab, supporting broader participation in cervical cancer screening programs. The self-collected swab requires no manual sample preparation by clinical laboratory technologists. This process will allow them to focus on higher-value work. Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company that focuses on the development, manufacturing, and sale of various medical supplies, devices, diagnostic products, and laboratory equipment. While we acknowledge the potential of BDX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Newsweek
2 hours ago
- Newsweek
Ice Cream Recall Map Shows States With New Warning
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. DFA Dairy Brands, LLC, is recalling the Friendly's brand of Cookies & Cream ice cream due to undeclared soy and wheat concerns. Newsweek reached out to the company via email on Wednesday for comment. Why It Matters Numerous recalls have been initiated this year due to the potential for damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or allergies every year. According to the U.S. Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. People with a wheat or soy allergy could experience a "serious or life-threatening allergic reaction if they consume these products," the FDA warns. What To Know In the alert, the FDA says that the recalled products were packaged mistakenly in Friendly's Vanilla Bean cartons with a Cookies & Cream lid. The recalled products were distributed through UNFI to retail locations in Pennsylvania, Maryland and Virginia. Below is a map showing the states impacted by the recall: The ice cream was sold in 48-fluid ounce containers with a best-by date of November 26, 2025. No other Friendly's products are impacted by the recall, the FDA alert notes. What People Are Saying The FDA in the alert, in part: "The voluntary recall was initiated after it was discovered that a limited quantity of Cookies & Cream ice cream was mistakenly packaged in Friendly's Vanilla Bean ice cream cartons that did not identify the soy and wheat ingredients. No illnesses or adverse reactions have been reported. This recall is being made with the knowledge of the U.S. Food and Drug Administration." In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news release, to inform the public of a voluntary product recall; the FDA shares that release on our website as a public service. "The FDA's role during a voluntary, firm-initiated, recall is to review the recall strategy, evaluate the health hazard presented by the product, monitor the recall, and as appropriate alert the public and other companies in the supply chain about the recall. "The FDA provides public access to information on recalls by posting a listing of recalls according to their classification in the FDA Enforcement Report, including the specific action taken by the recalling company. The FDA Enforcement Report is designed to provide a public listing of products in the marketplace that are being recalled." Additional information on recalls can be found via the FDA's Recalls, Market Withdrawals, & Safety Alerts. What Happens Next Customers who have purchased the recalled product are urged to return the ice cream to the original place of purchase for a refund, the FDA alert notes. People with additional questions may contact DFA Dairy Brands, LLC, via phone at 800- 587-2259. Further recalls or updates are possible as investigations continue, and consumers are encouraged to monitor FDA alerts for developments.
Yahoo
3 hours ago
- Yahoo
NFL smelling salts ban: NFLPA provides key updates on policy
The NFL announced Tuesday its teams would be prohibited from distributing smelling salts to its players during the league's 2025 season. However, the league did not actually ban the products from being used, as the NFLPA clarified Wednesday. "We were not notified of this club policy change before the memo was sent out," the NFLPA wrote in a message to its players, per ESPN. "To clarify, this policy does not prohibit player use of these substances, but rather it restricts clubs from providing or supplying them in any form. The NFL has confirmed this to us." The confusion stemmed from the NFL's initial memo to players, which explained why NFL clubs would no longer be permitted to distribute smelling salts to its players. "In 2024, the FDA issued a warning to companies that produce commercially available ammonia inhalants (AIs), as well as to consumers about the purchase and use of AIs, regarding the lack of evidence supporting the safety or efficacy of AIs marketed for improving mental alertness or boosting energy. The FDA noted potential negative effects from AI use. AIs also have the potential to mask certain neurologic signs and symptoms, including some potential signs of concussion. As a result, the NFL Head, Neck, and Spine Committee recommended prohibiting the use of AIs for any purpose during play in the NFL. "In light of this information, effective for the 2025 NFL season, clubs are prohibited from providing or supplying ammonia in any form at NFL games. For clarity, 'ammonia' refers to ammonia capsules, inhalers, ammonia in a cup, and any form of 'smelling salts.' This prohibition applies to all club personnel (including but not limited to team physicians, athletic trainers, strength and conditioning coaches and coaches or other personnel). The prohibition applies through the entirety of all NFL games, including during all pregame activities, and halftime, and applies on the sideline and in stadium locker rooms." Several NFL players took the memo to mean the use of smelling salts had been banned outright. That upset many, including San Francisco 49ers tight end George Kittle, who said he was "distraught all day" after reading the memo. "I'm an every drive guy," Kittle said of his use of smelling salts in an appearance on NFL Network. "I considered retirement. We got to figure out a middle ground here guys. Somebody help me out, somebody come up with a good idea… I miss those already." After the NFLPA's clarification, Kittle no longer has to worry about negotiating a middle ground. He will, however, have to provide his own stash of smelling salts if he wants to continue using them in 2025. This article originally appeared on USA TODAY: NFL players not banned from using smelling salts, NFLPA says
